-
1
-
-
9144224226
-
International Psychogeriatric Association Expert Meeting on DLB: Dementia with Lewy bodies
-
McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, et al. International Psychogeriatric Association Expert Meeting on DLB: Dementia with Lewy bodies. Lancet Neurol. 2004;3:19-28.
-
(2004)
Lancet Neurol
, vol.3
, pp. 19-28
-
-
McKeith, I.1
Mintzer, J.2
Aarsland, D.3
Burn, D.4
Chiu, H.5
Cohen-Mansfield, J.6
-
2
-
-
0006164301
-
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
-
1:STN:280:DyaK2s%2FmsF2gtw%3D%3D 8909416
-
McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47:1113-24.
-
(1996)
Neurology
, vol.47
, pp. 1113-1124
-
-
McKeith, I.G.1
Galasko, D.2
Kosaka, K.3
Perry, E.K.4
Dickson, D.W.5
Hansen, L.A.6
-
3
-
-
0035013468
-
The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease
-
1:STN:280:DC%2BD3M3ps1GqtQ%3D%3D 11376466
-
Ballard C, O'Brien J, Morris CM, Barber R, Swann A, Neill D, et al. The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease. Int J Geriatr Psychiatry. 2001;16:499-503.
-
(2001)
Int J Geriatr Psychiatry
, vol.16
, pp. 499-503
-
-
Ballard, C.1
O'Brien, J.2
Morris, C.M.3
Barber, R.4
Swann, A.5
Neill, D.6
-
4
-
-
0029880810
-
Cognitive decline in patients with Alzheimer's disease, vascular dementia and senile dementia of Lewy body type
-
1:STN:280:DyaK28zisVahsA%3D%3D 8670554
-
Ballard C, Patel A, Oyebode F, Wilcock G. Cognitive decline in patients with Alzheimer's disease, vascular dementia and senile dementia of Lewy body type. Age Ageing. 1996;25:209-13.
-
(1996)
Age Ageing
, vol.25
, pp. 209-213
-
-
Ballard, C.1
Patel, A.2
Oyebode, F.3
Wilcock, G.4
-
5
-
-
0031722580
-
Cognitive decline is faster in Lewy body variant than in Alzheimer's disease
-
1:STN:280:DyaK1czntlOktA%3D%3D 9710002
-
Olichney JM, Galasko D, Salmon DP, Hofstetter CR, Hansen LA, Katzman R, et al. Cognitive decline is faster in Lewy body variant than in Alzheimer's disease. Neurology. 1998;51:351-7.
-
(1998)
Neurology
, vol.51
, pp. 351-357
-
-
Olichney, J.M.1
Galasko, D.2
Salmon, D.P.3
Hofstetter, C.R.4
Hansen, L.A.5
Katzman, R.6
-
6
-
-
84857858429
-
Comparison of cognitive decline between dementia with Lewy bodies and Alzheimer's disease: A cohort study
-
Walker Z, McKeith I, Rodda J, Qassem T, Tatsch K, Booij J, et al. Comparison of cognitive decline between dementia with Lewy bodies and Alzheimer's disease: a cohort study. BMJ Open. 2012;2:e000380.
-
(2012)
BMJ Open
, vol.2
, pp. 000380
-
-
Walker, Z.1
McKeith, I.2
Rodda, J.3
Qassem, T.4
Tatsch, K.5
Booij, J.6
-
7
-
-
0034456480
-
Fall-related injuries in dementia with Lewy bodies (DLB) and Alzheimer's disease
-
1:STN:280:DC%2BD3c3ntVKjuw%3D%3D 10809918
-
Imamura T, Hirono N, Hashimoto M, Kazui H, Tanimukai S, Hanihara T, et al. Fall-related injuries in dementia with Lewy bodies (DLB) and Alzheimer's disease. Eur J Neurol. 2000;7:77-9.
-
(2000)
Eur J Neurol
, vol.7
, pp. 77-79
-
-
Imamura, T.1
Hirono, N.2
Hashimoto, M.3
Kazui, H.4
Tanimukai, S.5
Hanihara, T.6
-
8
-
-
58949095227
-
Risk factors for falls in community-dwelling patients with Alzheimer's disease and dementia with Lewy bodies: Walking with visuocognitive impairment may cause a fall
-
Kudo Y, Imamura T, Sato A, Endo N. Risk factors for falls in community-dwelling patients with Alzheimer's disease and dementia with Lewy bodies: walking with visuocognitive impairment may cause a fall. Dement Geriatr Cogn Disord. 2009;27:139-46.
-
(2009)
Dement Geriatr Cogn Disord
, vol.27
, pp. 139-146
-
-
Kudo, Y.1
Imamura, T.2
Sato, A.3
Endo, N.4
-
9
-
-
58349114729
-
Differences in clinical course between dementia with Lewy bodies and Alzheimer's disease
-
1:STN:280:DC%2BD1M%2FnsVyisA%3D%3D 19146642
-
Hanyu H, Sato T, Hirao K, Kanetaka H, Sakurai H, Iwamoto T. Differences in clinical course between dementia with Lewy bodies and Alzheimer's disease. Eur J Neurol. 2009;16:212-7.
-
(2009)
Eur J Neurol
, vol.16
, pp. 212-217
-
-
Hanyu, H.1
Sato, T.2
Hirao, K.3
Kanetaka, H.4
Sakurai, H.5
Iwamoto, T.6
-
10
-
-
0035021618
-
The characterisation and impact of 'fluctuating' cognition in dementia with Lewy bodies and Alzheimer's disease
-
1:STN:280:DC%2BD3M3ps1GqtA%3D%3D 11376465
-
Ballard C, Walker M, O'Brien J, Rowan E, McKeith I. The characterisation and impact of 'fluctuating' cognition in dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry. 2001;16:494-8.
-
(2001)
Int J Geriatr Psychiatry
, vol.16
, pp. 494-498
-
-
Ballard, C.1
Walker, M.2
O'Brien, J.3
Rowan, E.4
McKeith, I.5
-
11
-
-
34249939044
-
Patients with dementia with lewy bodies have more impaired quality of life than patients with Alzheimer disease
-
Boström F, Jönsson L, Minthon L, Londos E. Patients with dementia with lewy bodies have more impaired quality of life than patients with Alzheimer disease. Alzheimer Dis Assoc Disord. 2007;21:150-4.
-
(2007)
Alzheimer Dis Assoc Disord
, vol.21
, pp. 150-154
-
-
Boström, F.1
Jönsson, L.2
Minthon, L.3
Londos, E.4
-
12
-
-
84872086416
-
Examining carer stress in dementia: The role of subtype diagnosis and neuropsychiatric symptoms
-
Lee DR, McKeith I, Mosimann U, Ghosh-Nodyal A, Thomas AJ. Examining carer stress in dementia: the role of subtype diagnosis and neuropsychiatric symptoms. Int J Geriatr Psychiatry. 2013;28:135-41.
-
(2013)
Int J Geriatr Psychiatry
, vol.28
, pp. 135-141
-
-
Lee, D.R.1
McKeith, I.2
Mosimann, U.3
Ghosh-Nodyal, A.4
Thomas, A.J.5
-
13
-
-
33745813555
-
More severe functional impairment in dementia with lewy bodies than Alzheimer disease is related to extrapyramidal motor dysfunction
-
McKeith IG, Rowan E, Askew K, Naidu A, Allan L, Barnett N, et al. More severe functional impairment in dementia with lewy bodies than Alzheimer disease is related to extrapyramidal motor dysfunction. Am J Geriatr Psychiatry. 2006;14:582-8.
-
(2006)
Am J Geriatr Psychiatry
, vol.14
, pp. 582-588
-
-
McKeith, I.G.1
Rowan, E.2
Askew, K.3
Naidu, A.4
Allan, L.5
Barnett, N.6
-
14
-
-
0028279958
-
Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease
-
1:CAS:528:DyaK2cXkvVSitb4%3D 8018843
-
Perry EK, Haroutunian V, Davis KL, Levy R, Lantos P, Eagger S, et al. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. Neuroreport. 1994;5:747-9.
-
(1994)
Neuroreport
, vol.5
, pp. 747-749
-
-
Perry, E.K.1
Haroutunian, V.2
Davis, K.L.3
Levy, R.4
Lantos, P.5
Eagger, S.6
-
15
-
-
0027208615
-
Cholinergic transmitter and neurotrophic activities in Lewy body dementia: Similarity to Parkinson's and distinction from Alzheimer disease
-
1:STN:280:DyaK3szkvFCqtg%3D%3D 8347330
-
Perry EK, Irving D, Kerwin JM, McKeith IG, Thompson P, Collerton D, et al. Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer disease. Alzheimer Dis Assoc Disord. 1993;7:69-79.
-
(1993)
Alzheimer Dis Assoc Disord
, vol.7
, pp. 69-79
-
-
Perry, E.K.1
Irving, D.2
Kerwin, J.M.3
McKeith, I.G.4
Thompson, P.5
Collerton, D.6
-
16
-
-
34250213269
-
Efficacy and safety of galantamine in patients with dementia with Lewy bodies: A 24-week open-label study
-
1:CAS:528:DC%2BD2sXmt1Sqsb8%3D 17409748
-
Edwards K, Royall D, Hershey L, Lichter D, Hake A, Farlow M, et al. Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study. Dement Geriatr Cogn Disord. 2007;23:401-5.
-
(2007)
Dement Geriatr Cogn Disord
, vol.23
, pp. 401-405
-
-
Edwards, K.1
Royall, D.2
Hershey, L.3
Lichter, D.4
Hake, A.5
Farlow, M.6
-
17
-
-
17844406874
-
Long-Term use of rivastigmine in patients with dementia with Lewy bodies: An open-label trial
-
1:STN:280:DC%2BD3MvkvF2lug%3D%3D 11495394
-
Grace J, Daniel S, Stevens T, Shankar KK, Walker Z, Byrne EJ, et al. Long-Term use of rivastigmine in patients with dementia with Lewy bodies: an open-label trial. Int Psychogeriatr. 2001;13:199-205.
-
(2001)
Int Psychogeriatr
, vol.13
, pp. 199-205
-
-
Grace, J.1
Daniel, S.2
Stevens, T.3
Shankar, K.K.4
Walker, Z.5
Byrne, E.J.6
-
18
-
-
33644948649
-
Efficacy and safety of donepezil in patients with dementia with Lewy bodies: Preliminary findings from an open-label study
-
Mori S, Mori E, Iseki E, Kosaka K. Efficacy and safety of donepezil in patients with dementia with Lewy bodies: preliminary findings from an open-label study. Psychiatry Clin Neurosci. 2006;60:190-5.
-
(2006)
Psychiatry Clin Neurosci
, vol.60
, pp. 190-195
-
-
Mori, S.1
Mori, E.2
Iseki, E.3
Kosaka, K.4
-
19
-
-
33847354742
-
Effects of donepezil on central processing speed and attentional measures in Parkinson's disease with dementia and dementia with Lewy bodies
-
1:CAS:528:DC%2BD2sXjsF2gt7g%3D 17192712
-
Rowan E, McKeith IG, Saxby BK, O'Brien JT, Burn D, Mosimann U, et al. Effects of donepezil on central processing speed and attentional measures in Parkinson's disease with dementia and dementia with Lewy bodies. Dement Geriatr Cogn Disord. 2007;23:161-7.
-
(2007)
Dement Geriatr Cogn Disord
, vol.23
, pp. 161-167
-
-
Rowan, E.1
McKeith, I.G.2
Saxby, B.K.3
O'Brien, J.T.4
Burn, D.5
Mosimann, U.6
-
20
-
-
30344485150
-
A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies
-
Thomas AJ, Burn DJ, Rowan EN, Littlewood E, Newby J, Cousins D, et al. A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies. Int J Geriatr Psychiatry. 2005;20:938-44.
-
(2005)
Int J Geriatr Psychiatry
, vol.20
, pp. 938-944
-
-
Thomas, A.J.1
Burn, D.J.2
Rowan, E.N.3
Littlewood, E.4
Newby, J.5
Cousins, D.6
-
21
-
-
0034676757
-
Efficacy of rivastigmine in dementia with Lewy bodies: A randomised, double-blind, placebo-controlled international study
-
1:CAS:528:DC%2BD3MXnvV2r 11145488
-
McKeith I, Del Ser T, Spano P, Emre M, Wesnes K, Anand R, et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet. 2000;356:2031-6.
-
(2000)
Lancet
, vol.356
, pp. 2031-2036
-
-
McKeith, I.1
Del Ser, T.2
Spano, P.3
Emre, M.4
Wesnes, K.5
Anand, R.6
-
22
-
-
84864426175
-
Donepezil-DLB Study Investigators: Donepezil for dementia with Lewy bodies: A randomized, placebo-controlled trial
-
1:CAS:528:DC%2BC38XhtVOgsLbF 22829268
-
Mori E, Ikeda M, Kosaka K. Donepezil-DLB Study Investigators: Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial. Ann Neurol. 2012;72:41-52.
-
(2012)
Ann Neurol
, vol.72
, pp. 41-52
-
-
Mori, E.1
Ikeda, M.2
Kosaka, K.3
-
23
-
-
84884680030
-
Donepezil-DLB Study Investigators: Long-term safety and efficacy of donepezil in patients with dementia with Lewy bodies: Results from a 52-week, open-label, multicenter extension study
-
1:CAS:528:DC%2BC3sXhsFelsLvK 23949147
-
Ikeda M, Mori E, Kosaka K, Iseki E, Hashimoto M, Matsukawa N, et al. Donepezil-DLB Study Investigators: Long-term safety and efficacy of donepezil in patients with dementia with Lewy bodies: results from a 52-week, open-label, multicenter extension study. Dement Geriatr Cogn Disord. 2013;36:229-41.
-
(2013)
Dement Geriatr Cogn Disord
, vol.36
, pp. 229-241
-
-
Ikeda, M.1
Mori, E.2
Kosaka, K.3
Iseki, E.4
Hashimoto, M.5
Matsukawa, N.6
-
24
-
-
84925862152
-
Donepezil for dementia with Lewy bodies: A randomized placebo-controlled, confirmatory phase III trial
-
in press
-
Ikeda M, Mori E, Matsuo K, Nakagawa M, Kosaka K. Donepezil for dementia with Lewy bodies: a randomized placebo-controlled, confirmatory phase III trial. Alzheimers Res Ther. in press.
-
Alzheimers Res Ther
-
-
Ikeda, M.1
Mori, E.2
Matsuo, K.3
Nakagawa, M.4
Kosaka, K.5
-
25
-
-
0030958347
-
The Neuropsychiatric Inventory: Assessing psychopathology in dementia patients
-
1:STN:280:DyaK2s3pslKrtQ%3D%3D 9153155
-
Cummings JL. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology. 1997;48:S10-6.
-
(1997)
Neurology
, vol.48
, pp. 10-16
-
-
Cummings, J.L.1
-
26
-
-
0027985334
-
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
-
1:STN:280:DyaK2M%2FotlWisw%3D%3D 7991117
-
Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308-14.
-
(1994)
Neurology
, vol.44
, pp. 2308-2314
-
-
Cummings, J.L.1
Mega, M.2
Gray, K.3
Rosenberg-Thompson, S.4
Carusi, D.A.5
Gornbein, J.6
-
27
-
-
84895813596
-
Content validity and inter-rater reliability of the Cognitive Fluctuation Inventory
-
Hashimoto M, Manabe Y, Mori E, Hirono N, Kosaka K, Ikeda M. Content validity and inter-rater reliability of the Cognitive Fluctuation Inventory. Brain Nerve [in Japanese]. 2014;66:175-83.
-
(2014)
Brain Nerve [In Japanese]
, vol.66
, pp. 175-183
-
-
Hashimoto, M.1
Manabe, Y.2
Mori, E.3
Hirono, N.4
Kosaka, K.5
Ikeda, M.6
-
28
-
-
0014082977
-
Parkinsonism: Onset, progression and mortality
-
1:STN:280:DyaF2s7jvFSgsg%3D%3D 6067254
-
Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427-42.
-
(1967)
Neurology
, vol.17
, pp. 427-442
-
-
Hoehn, M.M.1
Yahr, M.D.2
-
29
-
-
0016823810
-
"mini-mental state. A practical method for grading the cognitive state of patients for the clinician
-
1:STN:280:DyaE28%2FntFKjtw%3D%3D 1202204
-
Folstein MF, Folstein SE, McHugh PR. "Mini-mental state. a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-98.
-
(1975)
J Psychiatr Res
, vol.12
, pp. 189-198
-
-
Folstein, M.F.1
Folstein, S.E.2
McHugh, P.R.3
-
30
-
-
0019206831
-
Relatives of the impaired elderly: Correlates of feelings of burden
-
1:STN:280:DyaL3M7jvFOhtw%3D%3D 7203086
-
Zarit SH, Reever KE, Bach-Peterson J. Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist. 1980;20:649-55.
-
(1980)
Gerontologist
, vol.20
, pp. 649-655
-
-
Zarit, S.H.1
Reever, K.E.2
Bach-Peterson, J.3
-
31
-
-
0000224448
-
Unified Parkinson's disease rating scale
-
Fahn SER: UPDRS Development Committee (eds) 2 Macmillan Healthcare Information New York 293-304
-
Fahn SER: UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn SMC, Calne D, Goldstein M, editors. Recent developments in Parkinson's disease, vol. 2. New York: Macmillan Healthcare Information; 1987. p. 153-63. 293-304.
-
(1987)
Recent Developments in Parkinson's Disease
, pp. 153-163
-
-
Fahn, S.M.C.1
Calne, D.2
Goldstein, M.3
-
32
-
-
0008682024
-
Long-term safety and efficacy of acetylcholinesterase inhibitor E2020 in patients with Alzheimer-type dementia: 52-week open label study
-
Tohgi H, Homma A, Imai Y, Udaka F, Takeda M, Nishimura T, et al. Long-term safety and efficacy of acetylcholinesterase inhibitor E2020 in patients with Alzheimer-type dementia: 52-week open label study. Clin Eval. 2000;28:97-126.
-
(2000)
Clin Eval
, vol.28
, pp. 97-126
-
-
Tohgi, H.1
Homma, A.2
Imai, Y.3
Udaka, F.4
Takeda, M.5
Nishimura, T.6
-
33
-
-
60749113888
-
Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: Results from a 52-week, open-label, multicenter, extension study in Japan
-
1:CAS:528:DC%2BD1MXivFyruro%3D 19246907
-
Homma A, Imai Y, Tago H, Asada T, Shigeta M, Iwamoto T, et al. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan. Dement Geriatr Cogn Disord. 2009;27:232-9.
-
(2009)
Dement Geriatr Cogn Disord
, vol.27
, pp. 232-239
-
-
Homma, A.1
Imai, Y.2
Tago, H.3
Asada, T.4
Shigeta, M.5
Iwamoto, T.6
|